← FDA DRUG APPROVALS
FDA ANDA · ANDA207334
BROMFENAC OPHTHALMIC SOLUTION, 0.07%
bromfenac sodium
Sponsor: APOTEX
APPLICATION
ANDA207334
TYPE
ANDA
ORIGINAL APPROVAL
2024-07-08
LATEST ACTION
2024-07-08
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription
Products
BROMFENAC SODIUMPrescription
BROMFENAC SODIUM EQ 0.07% ACID · SOLUTION/DROPS · OPHTHALMIC
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.